 - Clinically significative cardiac disease: infarct or CVA during 6 month before inclusion, unstable angina, congestive cardiac failure level II as defined by New York Heart Association NYHA or cardiac arrythmia needing a specific treatment which risk to interfere with the study, or uncontrolled arrythmia. 